Post

🗓 Pathoplexus turns ONE! 🎂🎉 In the past year we’ve grown from 4 pathogens to a truly global, community-driven platform for transparent, equitable & impactful pathogen sequence sharing. 📰 Read the full update: pathoplexus.org/news/2025-08... 1/10

A Year of Milestones 🌍 Together with our community we have: • Added mpox (Dec 2024) + RSV & HMPV (May 2025) • Received direct uploads from 5 continents - incl. more mpox in 2025 than other databases • Rolled out major software updates & new analysis integrations 2/10

We’ve also: • Enabled rapid public-health use while protecting publication rights via Restricted-Use sharing • Presented at WHO IPSN events, major conferences & workshops • Featured in Lancet Microbe, Science, Nature, and national media 3/10

And… 🏆 We received the 2024 Swiss National Open Research Data Prize for our commitment to openness & community governance – all while being powered largely by volunteer effort! 4/10

🎉 New in August: Measles virus joins Pathoplexus! Following strong community support, we added MeV data submission (with Open & Restricted-Use options, as always) and powerful search & data access for MeV pathoplexus.org/measles/search 5/10

Why now? • Measles cases have surged in the US in 2025 - real-time genomic tracking is vital • Global travel + declining vaccination rates raise outbreak risk • More labs are sequencing MeV than ever before- enabling insights into spread & evolution 6/10

Other news: We’ve received 🧬 256 new direct mpox sequences from Sierra Leone, Portugal, Germany, Côte d’Ivoire, DRC, Ireland & Central African Republic 🧬 308 new direct West Nile sequences from California & Nebraska, USA 7/10

💡 New tech: 🔁GISAID accessions can now be linked in metadata for supported pathogens 🖱️Drag your mouse over checkboxes to quickly select multiple sequences 🔎Find sequences faster than ever with the new Accession search at the top of the home page 8/10